Human epidermal keratinocytes death and expression of protein markers of apoptosis after ionizing radiation exposure
Purpose: Knowledge of the pathophysiology of the irradiated skin is important to understand the tolerance and cosmetic response of the human skin to radiation. There are limited studies on the effect of radiotherapy dosage and fraction size in inducing apoptotic cell death in human skin. The expression of apoptotic biomarkers within a controlled population in different fractionation schemes has also never been studied. This study aims to investigate radiation induced apoptotic cell death in human skin cells after fractionated radiation exposure and the expression of unique biomarkers that reflect cell death or biology using multiplexed immunoassays.
Methods: Breast skin biopsies were obtained from a single individual and divided into small pieces. Each piece was irradiated under different radiotherapy treatment fractionation schedules to a total dose of 50Gy. The irradiated skin tissues were analysed using Tunnel, immunohistochemistry and Western blot assays for expression of apoptotic keratinocytes and biomarkers (p53, p21, and PCNA). Haematoxylin and eosin (H&E) immunostaining was performed to study the morphological changes in the skin cells.
Results: Radiation is mostly absorbed by the epidermal layers and observed to damage the epidermal keratinocytes leading to the activation of apoptotic proteins. Apoptotic proteins (p53, p21 and PCNA) were confirmed to be up-regulated in radiation exposed skin cells as compared to normal skin cells with no radiation. There is strong correlation of apoptotic protein expressions with increased radiation dosage and dose fractionation. Statistical analysis with ANOVA revealed a significant increase of PCNA and p21 expression with increased radiation dosage and dose fractionation (p < 0.05). Immunohistochemically, 14 % (range 10.71% to 17.29%) of the keratinocytes were positive for PCNA and 22.5% (range 18.28% to 27.2%) for p21 after 2Gy of irradiation. The most widespread, intense and uniform staining for PCNA and p21 was observed in skin that had received 50Gy of irradiation. The maximum expression of p53 (range 37.09% to 50.91%) was reached at 10Gy.
Conclusion: Findings from this study will assist clinicians in predicting radiation induced skin toxicity with the current changes in radiation fractionation protocols.
Cite this article as: Wong S, Chor HH, Moothy S, Ong CT, Phan TT, Lu JJ. Human epidermal keratinocytes death and expression of protein markers of apoptosis after ionizing radiation exposure. Int J Cancer Ther Oncol 2013; 1(2):01027.
Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999; 353:1641-1648.
Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997; 337: 956-962.
Turesson, I. Individual variation and dose dependency in the progression rate of skin telangiectasia. Int J Radiat Oncol Biol Phys 1990; 19: 1569-1574.
Turesson I, Nyman J, Holmberg E, et al. Prognostic factors for acute and late skin reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys 1996; 36; 1065-1075.
Tucker SL, Turesson I, Thames HD. Evidence for individual differences in the radiosensitivity of human skin. Eur J Cancer 1992; 28A: 1783-1791.
Bernier J, Thames HD, Smith CD, Horiot JC. Tumor response, mucosal reactions and late effects after conventional and hyperfractionated radiotherapy. Radiother Oncol 1998; 47: 137-143.
Rojas A, Joiner MC. The influence of dose per fraction on repair kinetics. Radiother Oncol 1989; 14: 329-336.
Vicini FA, Baglan KL, Kestin LL, Mitchell C, Chen PY, Frazier RC, Edmundson G, Goldstein NS, Benitez P, Huang RR, Martinez A. Accelerated treatment of breast cancer. J Clin Oncol 2001; 19:1993-2001.
Jager JJ, Jansen RL, Arends JW. Clinical relevance of apoptotic markers in breast cancer not yet clear. Apoptosis 2002; 7: 361-365.
Menard C, Johann D, Lowenthal M, Muanza T, Sproull M, Ross S, et al. Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis. Cancer Res 2006; 66: 1844-1850.
Archambeau JO, Pezner R, Wasserman T. Pathophysiology of irradiated skin and breast. Int J Radiat Oncol Biol Phys 1995; 31:1171-1185.
Gorodetsky R, Lotan C, Piggot K, Pierce LJ, Polyansky I, et al. Late effects of dose fractionation on the mechanical properties of breast skin following post-lumpectomy radiotherapy. Int J Radiat Oncol Biol Phys 1999; 45:893-900.
Low WK, Tan MG, Sun L, Chua AW, Goh LK, Wang DY. Dose-dependant radiation-induced apoptosis in a cochlear cell-line. Apoptosis 2006; 11:2127-2136.
Ponten F, Lindman H, Bostrom A, Berne B, Bergh J. Induction of p53 expression in skin by radiotherapy and UV radiation: a randomized study. J Natl Cancer Inst 2001 ;93:128-133.
Faulhaber O, Bristow RG. Basis of cell kill folowing clinical radiotherapy, In M. Sluyser(ed), Application of Apoptosis to Cancer Treatment. Springer 2005; 293-320.
Hagan M, Yacoub A, Dent P. Ionizing radiation causes a dose-dependent release of transforming growth factor alpha in vitro from irradiated xenografts and during palliative treatment of hormone-refractory prostate carcinoma. Clin Cancer Res 2004; 10: 5724-5731.
Rubin P, Johnston CJ, Williams JP, McDonald S, Finkelstein JN. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 1995; 33:99-109.
Okunieff P, Chen Y, Maguire DJ, Huser AK. Molecular markers of radiation-related normal tissue toxicity. Cancer Metastasis Rev 2008; 27:363-374.
Kovacs CJ, Daly BM, Evans MJ, Johnke RM, Lee TK, et al. Cytokine profiles in patients receiving wide-field + prostate boost radiotherapy (xRT) for adenocarcinoma of the prostate. Cytokine 2003; 23:151-63.
Gu M, Dhanalakshmi S, Singh RP, Agarwal R. Dietary feeding of silibinin prevents early biomarkers of UVB radiation-induced carcinogenesis in SKH-1 hairless mouse epidermis. Cancer Epidemiol Biomarkers Prev 2005; 14:1344-9.
Mass P, Hoffmann K, Gambichler T, Altmeyer P, Mannherz HG. Premature keratinocyte death and expression of marker proteins of apoptosis in human skin after UVB exposure. Arch Dermatol Res 2003; 295:71-79.
Ahmed NU, Ueda M, Ichihashi M. Induced expression of p16 and p21 proteins in UVB-irradiated human epidermis and cultured keratinocytes. J Dermatol Sci 1999; 19:175-181.
Murphy M, Mabruk MJ, Lenane P, Liew A, McCann P, Buckley A, et al. The expression of p53, p21, Bax and induction of apoptosis in normal volunteers in response to different doses of ultraviolet radiation. Br J Dermatol 2002; 147:110-107.
Warbrick E. The puzzle of PCNA's many partners. Bioessays 2000; 22;997-1006.
Fotedar R, Bendjennat M, Fotedar A. Role of p21WAF1 in the cellular response to UV. Cell Cycle 2004; 3:134-137.
Wenz F, Azzam EI, Little JB. The response of proliferating cell nuclear antigen to ionizing radiation in human lymphoblastoid cell lines is dependent on p53. Radiat Res 1998; 149:32-40.
Moggs JG, Grandi P, Quivy JP, Jonsson ZO, Hubscher U, Becker PB, Almouzni G. A CAF-1-PCNA-mediated chromatin assembly pathway triggered by sensing DNA damage. Mol Cell Biol 2000; 20:1206-18.
This work is licensed under a Creative Commons Attribution 3.0 License.
International Journal of Cancer Therapy and Oncology (ISSN 2330-4049)
© International Journal of Cancer Therapy and Oncology (IJCTO)
To make sure that you can receive messages from us, please add the 'ijcto.org' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.